H19 and breast carcinoma: Additionally, they identified the ubiquitin ligase E3 family (c-CbI and CbI-b) as direct targets of miR-675 in breast cancer cells, providing novel mechanistic insights into a role of lncRNA H19 in breast cancer development [73].